Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $9,520 | 610 | 87.0% |
| Education | $802.13 | 28 | 7.3% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $600.00 | 1 | 5.5% |
| Gift | $16.25 | 1 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| PFIZER INC. | $1,198 | 84 | $0 (2024) |
| TherapeuticsMD, Inc. | $994.71 | 88 | $0 (2022) |
| Astellas Pharma US Inc | $975.95 | 30 | $0 (2024) |
| ABBVIE INC. | $942.70 | 53 | $0 (2024) |
| Allergan, Inc. | $815.27 | 73 | $0 (2020) |
| Exeltis, USA Inc. | $707.70 | 52 | $0 (2024) |
| Celularity, Inc. | $600.00 | 1 | $0 (2019) |
| Myovant Sciences Inc. | $510.76 | 36 | $0 (2022) |
| Sumitomo Pharma America, Inc. | $449.19 | 23 | $0 (2024) |
| AMAG Pharmaceuticals, Inc. | $426.84 | 22 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $734.63 | 34 | Astellas Pharma US Inc ($184.27) |
| 2023 | $1,458 | 70 | Sumitomo Pharma America, Inc. ($306.17) |
| 2022 | $1,843 | 101 | Myovant Sciences Inc. ($304.14) |
| 2021 | $1,805 | 118 | TherapeuticsMD, Inc. ($239.72) |
| 2020 | $870.92 | 66 | TherapeuticsMD, Inc. ($389.33) |
| 2019 | $1,856 | 98 | Celularity, Inc. ($600.00) |
| 2018 | $1,150 | 68 | AMAG Pharmaceuticals, Inc. ($364.44) |
| 2017 | $1,222 | 85 | PFIZER INC. ($335.38) |
All Payment Transactions
640 individual payment records from CMS Open Payments — Page 1 of 26
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | Astellas Pharma US Inc | — | Education | In-kind items and services | $99.00 | General |
| 12/13/2024 | Sumitomo Pharma America, Inc. | MYFEMBREE (Drug) | Food and Beverage | In-kind items and services | $15.33 | General |
| Category: HORMONE THERAPY | ||||||
| 11/19/2024 | Exeltis, USA Inc. | SLYND (Drug) | Food and Beverage | In-kind items and services | $16.75 | General |
| Category: CONTRACEPTIVE | ||||||
| 11/08/2024 | Hologic Sales and Service, LLC | ACESSA PROVU SYSTEM (Device) | Food and Beverage | In-kind items and services | $33.35 | General |
| Category: Surgical | ||||||
| 11/07/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $28.79 | General |
| Category: Biological | ||||||
| 10/31/2024 | Exeltis, USA Inc. | SLYND (Drug) | Food and Beverage | In-kind items and services | $6.73 | General |
| Category: CONTRACEPTIVE | ||||||
| 10/29/2024 | Sage Therapeutics, Inc. | ZURZUVAE (Drug) | Food and Beverage | In-kind items and services | $14.12 | General |
| Category: PSYCHIATRY/PSYCHOLOGY | ||||||
| 10/22/2024 | ABBVIE INC. | LO LOESTRIN FE (Drug) | Food and Beverage | In-kind items and services | $23.47 | General |
| Category: WOMENS HEALTH | ||||||
| 10/22/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $11.60 | General |
| Category: UROLOGY | ||||||
| 10/18/2024 | Ethicon US, LLC | Enseal X1 (Device), ETHICON | Food and Beverage | In-kind items and services | $36.00 | General |
| Category: Energy | ||||||
| 10/15/2024 | Exeltis, USA Inc. | SLYND (Drug) | Food and Beverage | In-kind items and services | $10.99 | General |
| Category: CONTRACEPTIVE | ||||||
| 09/12/2024 | Exeltis, USA Inc. | TYBLUME (Drug) | Food and Beverage | In-kind items and services | $11.70 | General |
| Category: CONTRACEPTIVE | ||||||
| 08/22/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $32.98 | General |
| Category: Biological | ||||||
| 08/20/2024 | Exeltis, USA Inc. | TYBLUME (Drug) | Food and Beverage | In-kind items and services | $11.98 | General |
| Category: CONTRACEPTIVE | ||||||
| 08/06/2024 | Exeltis, USA Inc. | TYBLUME (Drug) | Food and Beverage | In-kind items and services | $11.08 | General |
| Category: CONTRACEPTIVE | ||||||
| 08/06/2024 | Exeltis, USA Inc. | TYBLUME (Drug) | Food and Beverage | In-kind items and services | $4.16 | General |
| Category: CONTRACEPTIVE | ||||||
| 08/05/2024 | Sumitomo Pharma America, Inc. | MYFEMBREE (Drug) | Food and Beverage | In-kind items and services | $19.18 | General |
| Category: HORMONE THERAPY | ||||||
| 07/11/2024 | Exeltis, USA Inc. | SLYND (Drug) | Food and Beverage | In-kind items and services | $11.92 | General |
| Category: CONTRACEPTIVE | ||||||
| 07/09/2024 | CooperSurgical, Inc. | Summit Doppler (Device) | Food and Beverage | In-kind items and services | $33.69 | General |
| Category: Devices | ||||||
| 06/20/2024 | Exeltis, USA Inc. | SLYND (Drug) | Food and Beverage | In-kind items and services | $8.30 | General |
| Category: CONTRACEPTIVE | ||||||
| 06/06/2024 | Exeltis, USA Inc. | SLYND (Drug) | Food and Beverage | In-kind items and services | $12.20 | General |
| Category: CONTRACEPTIVE | ||||||
| 05/10/2024 | Ethicon US, LLC | Enseal X1 (Device) | Food and Beverage | In-kind items and services | $17.00 | General |
| Category: Energy | ||||||
| 05/06/2024 | Exeltis, USA Inc. | SLYND (Drug) | Food and Beverage | In-kind items and services | $11.90 | General |
| Category: CONTRACEPTIVE | ||||||
| 05/02/2024 | Organon Llc | NEXPLANON (Drug) | Food and Beverage | In-kind items and services | $12.72 | General |
| Category: ETONOGESTREL | ||||||
| 04/22/2024 | PFIZER INC. | PREMARIN (Drug), ESTRING, DUAVEE | Food and Beverage | In-kind items and services | $21.71 | General |
| Category: WOMENS HEALTH | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 8 | 612 | 623 | $56,204 | $24,921 |
| 2022 | 8 | 570 | 579 | $43,931 | $19,847 |
| 2021 | 8 | 566 | 589 | $45,445 | $20,610 |
| 2020 | 8 | 445 | 449 | $34,085 | $14,654 |
All Medicare Procedures & Services
32 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 106 | 107 | $21,400 | $10,333 | 48.3% |
| 76830 | Ultrasound scan of uterus, ovaries, tubes, cervix and pelvic area through vagina | Office | 2023 | 39 | 40 | $10,000 | $3,526 | 35.3% |
| 76856 | Complete ultrasound scan of pelvis | Office | 2023 | 39 | 40 | $8,000 | $3,258 | 40.7% |
| Q0091 | Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory | Office | 2023 | 52 | 52 | $5,200 | $2,308 | 44.4% |
| G0101 | Cervical or vaginal cancer screening; pelvic and clinical breast examination | Office | 2023 | 54 | 54 | $4,050 | $2,157 | 53.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 26 | 33 | $3,960 | $2,051 | 51.8% |
| 82271 | Specimen analysis for blood | Office | 2023 | 155 | 156 | $2,184 | $807.95 | 37.0% |
| 81002 | Urinalysis, manual test | Office | 2023 | 141 | 141 | $1,410 | $480.81 | 34.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 66 | 66 | $13,200 | $5,946 | 45.0% |
| Q0091 | Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory | Office | 2022 | 79 | 79 | $7,900 | $3,566 | 45.1% |
| G0101 | Cervical or vaginal cancer screening; pelvic and clinical breast examination | Office | 2022 | 79 | 79 | $5,925 | $3,241 | 54.7% |
| 76830 | Ultrasound scan of uterus, ovaries, tubes, cervix and pelvic area through vagina | Office | 2022 | 21 | 23 | $5,750 | $2,079 | 36.2% |
| 76856 | Complete ultrasound scan of pelvis | Office | 2022 | 21 | 22 | $4,400 | $1,907 | 43.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 22 | 28 | $3,360 | $1,877 | 55.8% |
| 82271 | Specimen analysis for blood | Office | 2022 | 144 | 144 | $2,016 | $757.03 | 37.6% |
| 81002 | Urinalysis, manual test | Office | 2022 | 138 | 138 | $1,380 | $474.82 | 34.4% |
| Q0091 | Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory | Office | 2021 | 90 | 90 | $9,000 | $4,107 | 45.6% |
| G0101 | Cervical or vaginal cancer screening; pelvic and clinical breast examination | Office | 2021 | 91 | 91 | $6,825 | $3,742 | 54.8% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 44 | 45 | $9,000 | $3,588 | 39.9% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 36 | 44 | $5,280 | $2,922 | 55.3% |
| 76830 | Ultrasound pelvis through vagina | Office | 2021 | 22 | 27 | $6,750 | $2,610 | 38.7% |
| 76856 | Ultrasound of pelvis, complete, not pregnancy related | Office | 2021 | 22 | 27 | $5,400 | $2,470 | 45.7% |
| 82271 | Specimen analysis for blood | Office | 2021 | 133 | 135 | $1,890 | $718.20 | 38.0% |
| 81002 | Urinalysis, manual test | Office | 2021 | 128 | 130 | $1,300 | $452.40 | 34.8% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 75 | 75 | $15,000 | $5,979 | 39.9% |
About Dr. Michael Beitle, M.D
Dr. Michael Beitle, M.D is a Obstetrics & Gynecology healthcare provider based in Providence, Rhode Island. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/01/2006. The National Provider Identifier (NPI) number assigned to this provider is 1659318392.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Michael Beitle, M.D has received a total of $10,939 in payments from pharmaceutical and medical device companies, with $734.63 received in 2024. These payments were reported across 640 transactions from 39 companies. The most common payment nature is "Food and Beverage" ($9,520).
As a Medicare-enrolled provider, Beitle has provided services to 2,193 Medicare beneficiaries, totaling 2,240 services with total Medicare billing of $80,031. Data is available for 4 years (2020–2023), covering 32 distinct procedure/service records.
Practice Information
- Specialty Obstetrics & Gynecology
- Other Specialties Obstetrics & Gynecology
- Location Providence, RI
- Active Since 06/01/2006
- Last Updated 07/09/2020
- Taxonomy Code 207V00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1659318392
Products in Payments
- LO LOESTRIN FE (Drug) $1,346
- MYFEMBREE (Drug) $948.35
- PREMARIN (Drug) $807.99
- SLYND (Drug) $668.78
- IMVEXXY (Drug) $550.64
- Xulane (Drug) $410.81
- ANNOVERA (Drug) $392.19
- INTRAROSA (Drug) $383.80
- Twirla (Drug) $336.00
- PREMARIN ORALS (Drug) $303.79
- Desara (Device) $301.50
- Phexxi (Drug) $220.43
- NEXPLANON (Drug) $218.01
- Balcoltra (Drug) $214.90
- Veozah (Drug) $172.55
- MYRBETRIQ (Drug) $163.62
- Myrbetriq (Drug) $150.90
- SOLOSEC (Drug) $143.67
- Osphena (Drug) $138.37
- Lupron (Drug) $133.13
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Obstetrics & Gynecology Doctors in Providence
Dr. Methodius Tuuli, Md, MD
Obstetrics & Gynecology — Payments: $40,003
Jennifer Gass, Md, MD
Obstetrics & Gynecology — Payments: $37,739
Lisa Boyle, Md, MD
Obstetrics & Gynecology — Payments: $29,387
Gary Wharton, Md, MD
Obstetrics & Gynecology — Payments: $21,700
Renee Eger, Md, MD
Obstetrics & Gynecology — Payments: $13,199
Michele Gange, Md, MD
Obstetrics & Gynecology — Payments: $6,666